P2-CRC-D0918Active studySynthetic mock data

Sara Khan — D0918-CRC-007

Stage III CRC s/p resection, ctDNA+ · Arm A · enrolled 2025-09-22

Subject ID

s-0918-007

MRN

MRN 6025307

Age / sex

56 / F

ECOG

0

Best response

PR

Σ Δ at Wk 32

7 mm · -56.2%

nadir 0.0%

RECIST 1.1 — Target lesions

Serial measurements (mm) and per-visit response

Sum-of-diameters; % from baseline (PR ≤ -30%); % from nadir (PD ≥ +20% absolute ≥ 5 mm)

Best response: PR
LesionModality
Baseline2025-09-04
Wk 82025-10-30
Wk 162025-12-25
Wk 242026-02-19
Wk 322026-04-16

Pelvic node

CT1612987
Sum of diametersmm1612987
% from baseline0.0%-25.0%-43.7%-50.0%-56.2%
% from nadir0.0%0.0%0.0%0.0%0.0%
RECIST responseNEPRPRPRPR

Non-target lesions

Per-visit qualitative status (presence / absence / equivocal / new)

LesionBaselineWk 8Wk 16Wk 24Wk 32
Anastomotic thickeningpresentpresentequivocalabsentabsent

Other subjects in P2-CRC-D0918

23 subjects across all studies in workspace.